Iridex Revenue Growth Rates (IRIX), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Iridex Corp  (NASDAQ: IRIX)
 

IRIX's Revenue Growth by Quarter and Year

Iridex's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IRIX Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter January -
3rd Quarter October -
2nd Quarter July 12.57
1st Quarter April 11.74
FY 24.31

IRIXs Annual Revenue
Iridex's Revenue in the fiscal year 2026 $ 52.23 millions
Iridex's Revenue in the fiscal year 2024 $ 48.50 millions
Iridex's Revenue in the fiscal year 2023 $ 51.81 millions
Iridex's Revenue in the fiscal year 2022 $ 56.37 millions
Iridex's Revenue in the fiscal year 2021 $ 53.90 millions




IRIX Revenue second quarter 2026 Y/Y Growth Comment
Iridex Corp reported decrease in Revenue in the second quarter 2026 by -0.9% to $ 12.57 millions, from the same quarter in 2025.
The decrease in the second quarter 2026 Iridex Corp's Revenue compares unfavorably to the Company's average Revenue growth of 3.68%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 130 other companies have achieved higher Revenue growth. While Iridex Corp' s Revenue decline of -0.9% ranks overall at the positon no. 2479 in the second quarter 2026.


IRIX Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter January - 8.31 % -2.16 % -8.62 %
3rd Quarter October - 6.1 % -10.3 % -12.72 %
2nd Quarter July -0.9 % 4.45 % -1.78 % -6.86 %
1st Quarter April 6.15 % -3.49 % -11.44 % -0.31 %
FY   - 4.04 % -6.37 % -

Financial Statements
Iridex's second quarter 2026 Revenue $ 12.57 millions IRIX's Income Statement
Iridex's second quarter 2025 Revenue $ 12.68 millions Quarterly IRIX's Income Statement


IRIX Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter January - 22.56 % 20.05 % 10.06 %
3rd Quarter October - -5.28 % -6.75 % 2.1 %
2nd Quarter July 7.04 % 14.65 % 5.93 % -4.48 %
1st Quarter April -20.24 % -18.62 % -17.49 % -14.87 %
FY (Year on Year)   - 4.04 % -6.37 % -


Back to IRIX Growth rate Comparisons >> Back to IRIX Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #131
Healthcare Sector #362
Overall #2479

Revenue Y/Y Growth Statistics
High Average Low
48.3 % 3.68 % -17.03 %
(Jan 01 2022)   (Sep 26 2020)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #131
Healthcare Sector #362
Overall #2479
Revenue Y/Y Growth Statistics
High Average Low
48.3 % 3.68 % -17.03 %
(Jan 01 2022)   (Sep 26 2020)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Iridex's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
41.55 % 1.81 % -31.06 %
(Sep 26 2020)  


IRIX's II. Quarter Q/Q Revenue Comment
Iridex Corp achieved in the II. Quarter 2026 above company average sequential Revenue increase of 7.04%, to $ 12.57 millions, from $11.74 millions in the first quarter.

Within Medical Equipment & Supplies industry 38 other companies have achieved higher Revenue quarter on quarter growth. While Iridex's Revenue growth quarter on quarter, overall rank is 980.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #39
Healthcare Sector #146
Overall #980
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #39
Healthcare Sector #146
Overall #980
Revenue Q/Q Growth Statistics
High Average Low
41.55 % 1.81 % -31.06 %
(Sep 26 2020)  


IRIX's II. Quarter Q/Q Revenue Comment
Iridex Corp achieved in the II. Quarter 2026 above company average sequential Revenue increase of 7.04%, to $ 12.57 millions, from $11.74 millions in the first quarter.

Within Medical Equipment & Supplies industry 38 other companies have achieved higher Revenue quarter on quarter growth. While Iridex's Revenue growth quarter on quarter, overall rank is 980.


Iridex's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jul 04 2026)		 12 Months Ending
(Apr 04 2026)		 12 Months Ending
(Jan 03 2026)		 12 Months Ending
(Sep 27 2025)		 12 Months Ending
(Jun 28 2025)
Cumulative Revenue 12 Months Ending $ 51.04 $ 51.16 $ 50.47 $ 49.34 $ 48.65
Y / Y Revenue Growth (TTM) 4.93 % 6.36 % 4.07 % 1.1 % -2.9 %
Year on Year Revenue Growth Overall Ranking # 2826 # 2447 # 2629 # 2165 # 2391
Seqeuential Revenue Change (TTM) -0.23 % 1.36 % 2.31 % 1.42 % 1.14 %
Seq. Revenue Growth (TTM) Overall Ranking # 2479 # 2221 # 2298 # 2410 # 1931


Cumulative Revenue growth Comment
Assuming the Iridex's fiscal year would have ended in Jul 04 2026, Iridex would have reprted above average annual Revenue improvement of 4.93% year on year, of $ 51 millions.
This marks a slow-down of the companys growth trends and from the 6.36% growth in Apr 04 2026.

In the Healthcare sector 401 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2447 to 2826.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 131
Healthcare Sector # 402
Overall # 2826

Revenue TTM Y/Y Growth Statistics
High Average Low
48.3 %
 3.68 %
-17.03 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 131
Sector # 362
S&P 500 # 2479
Cumulative Revenue growth Comment
Assuming the Iridex's fiscal year would have ended in Jul 04 2026, Iridex would have reprted above average annual Revenue improvement of 4.93% year on year, of $ 51 millions.
This marks a slow-down of the companys growth trends and from the 6.36% growth in Apr 04 2026.

In the Healthcare sector 401 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2447 to 2826.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 131
Healthcare Sector # 402
Overall # 2826

Revenue TTM Y/Y Growth Statistics
High Average Low
48.3 %
3.68 %
-17.03 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 131
Sector # 362
S&P 500 # 2479




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
IRIX's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Jul 04 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jul 04 2026
Lakeland Industries Inc -4.49%$ -4.490 millions
Kewaunee Scientific Corporation-6.50%$ -6.499 millions
Nutriband Inc -29.71%$ -29.711 millions


About Iridex Revenue Growth Rates (IRIX), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Iridex Corp (CIK 1006045).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-355641
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Iridex Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.